对超级分子作为化学药物的审查
ChengHe Zhou1, LinLing Gan2, YiYi Zhang1
1School of Chemistry and Chemical Engineering, Southwest University, Chongqing, 400715 China.
概括
由非共价键形成的超分子药物提供增强的生物可用性,降低毒性和提高疗效. 本综述探讨了它们的发展和各种治疗应用,强调了它们在医学中的巨大潜力.
科学领域:
- 超分子药物化学 超分子药物化学
- 制药科学 制药科学
- 跨学科研究跨学科的研究.
背景情况:
- 超分子化学正在扩展到制药科学,创造了一个超分子药物化学的新领域.
- 超分子药物是通过非共价键形成的超分子,许多已经在临床使用中.
- 这些药物提供了潜在的优势,如成本更低,生物可用性更高,生物相容性更好,毒性降低.
研究的目的:
- 定义超分子药物和超分子化学药物的概念.
- 系统地审查近期在超分子药物研发方面的进展.
- 介绍超分子药物的未来前景和潜在应用.
主要方法:
- 关于制药科学中的超分子化学的文献综述.
- 在各种治疗领域分析超分子药物应用.
- 讨论超分子药物的优势和潜力.
主要成果:
- 超分子药物显示出改善生物可用性,生物相容性和药物向性的潜力.
- 它们在减少多药耐药性,毒性和不良影响方面表现有前途.
- 应用范围包括抗瘤,抗炎,止痛,抗疟,抗菌,抗真菌,抗病毒,抗和心血管药物,以及成像药物.
结论:
- 超分子药物是一个快速发展的领域,具有显著的治疗潜力.
- 它们独特的特性比传统的化学药物提供了优势.
- 预计持续的研发将扩大其临床应用.
相关概念视频
Effects of Chemicals: Overview
1.3K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.3K
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Structure-Activity Relationships and Drug Design
710
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
710
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K


